Insights
Insights From Our Experts
Articles
Peeking Behind the PBM-lead GPO Curtain
‘PBM-lead GPO,’ a Newly Created Term to Describe Large Scale PBM-Owned Rebate Aggregators PBM-led group purchasing organizations (GPOs) are not true group purchasing organizations in scope, nor are they pure rebate aggregators. Rather, PBM-lead GPOs are…
Elevating Field Reimbursement Manager Performance through Insights & Comparative Data
“Elevating Field Reimbursement Managers’ Performance through Customer-based Insights and Comparative Data,” authored by David Frey, Principal, Specialty Consulting, EVERSANA and Lee Ann Steadman, Senior Vice President, Specialty Consulting, EVERSANA explores the evolving role of Field Reimbursement…
Breaking Down Q1 2023 Digital Health Policy Updates
Insights and Implications on AI/ML Software, Companion Apps for Pharma, Digital Diagnostics, VR Software, Breakthrough Devices, and More There was a barrage of activity by FDA in Digital Health at the end of 2022, including the…
Use of Machine Learning to Accurately Size Market Potential and Optimize Sales and Marketing Resources
Machine Learning as a strategic lever in healthcare. Recent advances in Machine Learning (ML) now make it possible for pharmaceutical companies to more accurately identify patient populations, including misdiagnosed patients with rare diseases and other diseases…
Achieving Digital Enlightenment in 2023 and Beyond
As evolving technologies and societal changes continue to push the use of digital channels and media, the reality is that healthcare professionals, patients and other key stakeholders are increasingly ‘digital natives’, who expect new ways of interacting.…
Case Study: Optimizing use of Field Reimbursement Managers
Navigating the complexities of insurance coverage can be a time consuming and challenging task. Field Reimbursement Managers (FRMs) were introduced as a way to help healthcare providers address issues or challenges related to securing timely access…
Case Study: Waste Reduction through Packaging Optimization
Pharmaceutical companies are being challenged to develop more effective delivery mechanisms of their therapies in order to reduce the amount of product waste. Recent changes in legislation, including the Waste Reduction Act of 2022 and adoption…
Video: New Cardiovascular Events after COVID-19 Infection
As we continue to learn more about COVID-19 and how the virus impacts the entire body, more information is coming to light regarding its impact specific to the heart and cardiovascular system. The cardiovascular complications of…
Next Generation Brand Planning: Fueling Brand Plan Efficiency Through Seamless Integration
Pharmaceutical companies are facing mounting pressures to better integrate and streamline their annual brand planning approaches to meet stakeholder needs and brand and portfolio goals. Despite being one of the most important commercial exercises in any…
Successfully Navigating Self-Commercialisation in Europe
Introduction As discussed in our previous paper, Successful Launches in Europe: Complex, But Not Complicated?,, Europe is one of the world’s largest and most important regions of focus for pharmaceutical and biotechnology manufacturers looking to treat…